VANCOUVER, British Columbia and LAS VEGAS, July 26, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6), a fast-growing telehealth platform enabling flexible home healthcare, in partnership with VS Digital Health Inc. (“VS Digital”) is preparing to launch a new website booking system and market place supported by a dispatch call centre (the “Dispatch Call Centre”), called “MobileMedIV.com”, which provides customers a streamlined approach to inquire about services offered, receiving consultations and booking appointments for IV therapy and other services.

Through Hydreight’s partnership with VS Digital, the Company has been actively developing and integrating new technologies and innovative applications to create an efficient and robust platform that enhances the accessibility of mobile health. MobileMedIV.com will serve as a user-friendly platform, allowing seamless inquiries and service booking with a Hydreight Business Partner (“Business Partner”). Furthermore, customers will have access to top-notch consultation services provided by Registered Nurses (“RNs”),ensuring the highest standard of care. By eliminating this bottleneck, Hydreight anticipates a  boost in customer satisfaction, improved customer retention rates, and a substantial increase in the number of bookings.

MobileMedIV.com Highlights:

• Introducing an Innovative and Streamlined Approach to Inquiries and Service Bookings with Our Business Partner
  • The Dispatch Call Centre is staffed with a team of highly qualified RNs, dedicated to helping customers find the most suitable services for their unique requirements. Hydreight’s RNs provide expert consultations and efficiently schedule appointments with the nearest available Business Partner. Additionally, inquiries can also be made conveniently through our online chat function or via SMS texting, ensuring seamless communication.
    

• Skip the App Download for Booking Services!
  • Customers no longer need to download the app to book our services. Customers can simply visit our website to access the convenient booking system directly. Please note that the mobile app will still be required for a medical screening call and completing any necessary forms, but these steps can easily handled after a booking is complete.
    

• MobileMedIV.com will Soft Launch in August 2023, With Initial Services of Mobile IV Drips and IV shots.
  

“Our primary objective is to create a seamless connection between compliance and patient convenience, empowering nurses and other licensed healthcare professionals to offer a comprehensive range of in-home services, including the highly sought-after IV Drip Therapy," said Shane Madden, CEO of Hydreight.

"Hydreight’s telehealth platform is dedicated to providing flexible home healthcare, and in collaboration with VS Digital, we extend our support to healthcare providers by assisting with their marketing efforts, ultimately enhancing the end-user experience for a smoother and more convenient journey.”

• MobileMedIV.com and Dispatch Call Centre
  

As an industry leader, Hydreight is committed to consistently delivering the best of care mobile health services. From expert consultations to tailored assessments of their specific needs, we aim to streamline the process, ensuring a streamline and time-efficient experience from start to finish. Given the projected growth of the US home healthcare services market, estimated to reach $153.19 billion by 2029 with a CAGR of 7.2% in the forecast period, Hydreight is well positioned to capitalize on this growing trend and further reinforce its position as a market leader.

In Partnership with VS Digital Health, the Company has developed a new website and marketplace to revolutionize the way customers access services. The new booking system will enable customers to effortlessly book appointments or contact the Dispatch Call Centre in order to inquire and book any of the services offered by Business Partners who are on the Hydreight premium package.

Customers will have access to a Dispatch Call Centre where a team of qualified RNs will be able to assist customers in finding the right services for their specific needs, such as drip therapy, and can receive consultations on the spot. The Dispatch Call Centre Team is also able to book appointments with Business Partners located in their respective vicinity so that inquiries can be turned into active customers in one call.

Hydreight Business Partners and providers have the exclusive opportunity to be prominently featured and listed on the website booking system, providing additional exposure and acting as a sales funnel for potential new customers. Premium package Business Partners can enhance their visibility, reach a wider audience of potential customers, and have appointments booked for them through the Dispatch Call Centre.

August 2023 – SOFT LAUNCH!

Hydreight plans to soft launch MobileMedIV.com in August 2023 and expand the range of services being offered by the end of August. IV Drips and IV Shots will be the initial services available during the soft launch period.

Other Direct Booking Features – QR Code

In addition to MobileMedIV.com, customers can simply scan a unique QR Code that will allow them to book directly from a Business Partner’s website, business card, flier or banner. Business Partners provide an efficient booking method, and customers no longer need to download the app to book an appointment.

The Company also announces entering into an investor relations agreement with IR Labs Inc. (“irlabs“) to provide the Company with investor relations services, with a primary focus on developing and managing an investor relations and communications.

Pursuant to the agreement with irlabs dated July 21, 2023, irlabs has agreed to provide investor relations and communications services to the Company in exchange for a monthly fee of $7,500 for the first four months and $10,000 each month thereafter. The services include developing and managing an investor relations and communications program, including stakeholder relations. The Company will also reimburse irlabs for all reasonable out-of-pocket expenses plus $300 per month to cover subscription fees for market intelligence platforms. The term of the agreement is for a period of four months ending November 30, 2023, and on a month-to-month basis thereafter. The agreement remains subject to acceptance by the TSX Venture Exchange. The contact person, address, email, and telephone number for irlabs are as follows: Alyssa Barry (Principal and Co-Founder), 400-22 E 5th Ave., Vancouver, BC, V5T 1G8, alyssa@irlabs.ca, 1-833-947-5227.

On behalf of the Board of Directors
Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.
www.hydreight.com
Telephone: (480) 790 6886

For further information about Hydreight, please contact:

Investor Relations: Abbey Vogt
Email: ir@hydreight.com; Telephone: (480) 790 6886

About Hydreight Technologies Inc.

Hydreight Technologies Inc. (TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6) is a home healthcare and wellness platform, and medical network that bridges the gap between provider compliance and patient convenience, empowering nurses, med spa technicians, and other licensed healthcare professionals to deliver services independently, on their own terms, or add mobile services to existing location-based operations. The network offers medical director oversight, liability insurance, competitively priced prescriptions via a 503B licensed pharmacy, and more. The platform includes a built-in, easy-to-use suite of fully-integrated tools for accounting, documentation, sales, inventory, booking, managing patient data, and more, making it possible to deliver fully-compliant mobile medicine across 50 states. Learn more at Hydreight.com.

Patients can download the Hydreight Wellness App from the Apple App store or Google Play Store, and prospective Business Partners can sign up at: Hydreight.com/start-a-business/

Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.

Cautionary Note Regarding Forward-Looking Information

This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect”, “Approximately” or similar expressions and includes information regarding the launch date of MedicalMedIV.com, and the anticipated effect on bookings and customer retention rates.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects the Company’s management’s expectations, estimates or predictions concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company’s shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.